Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.

Lopez CK, Noguera E, Stavropoulou V, Robert E, Aid Z, Ballerini P, Bilhou-Nabera C, Lapillonne H, Boudia F, Thirant C, Fagnan A, Arcangeli ML, Kinston SJ, Diop M, Job B, Lecluse Y, Brunet E, Babin L, Villeval JL, Delabesse E, Peters AHFM, Vainchenker W, Gaudry M, Masetti R, Locatelli F, Malinge S, Nerlov C, Droin N, Lobry C, Godin I, Bernard OA, Göttgens B, Petit A, Pflumio F, Schwaller J, Mercher T.

Cancer Discov. 2019 Dec;9(12):1736-1753. doi: 10.1158/2159-8290.CD-18-1463. Epub 2019 Oct 29.

PMID:
31662298
2.

Natural history and cell of origin of TC F3-ZN F384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL.

Bueno C, Tejedor JR, Bashford-Rogers R, González-Silva L, Valdés-Mas R, Agraz-Doblás A, Díaz de la Guardia R, Ribera J, Zamora L, Bilhou-Nabera C, Abermil N, Guermouche H, Gouache E, Leverger G, Fraga MF, Fernández AF, Ballerini P, Varela I, Menendez P.

Blood. 2019 Sep 12;134(11):900-905. doi: 10.1182/blood.2019000893. Epub 2019 Jun 20. No abstract available.

PMID:
31221673
3.

Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia.

Beke A, Laplane L, Riviere J, Yang Q, Torres-Martin M, Dayris T, Rameau P, Saada V, Bilhou-Nabera C, Hurtado A, Lordier L, Vainchenker W, Figueroa ME, Droin N, Solary E.

Haematologica. 2020 Jan;105(1):112-123. doi: 10.3324/haematol.2018.208488. Epub 2019 May 2.

4.

HIV-1 Tat protein induces DNA damage in human peripheral blood B-lymphocytes via mitochondrial ROS production.

El-Amine R, Germini D, Zakharova VV, Tsfasman T, Sheval EV, Louzada RAN, Dupuy C, Bilhou-Nabera C, Hamade A, Najjar F, Oksenhendler E, Lipinski M, Chernyak BV, Vassetzky YS.

Redox Biol. 2018 May;15:97-108. doi: 10.1016/j.redox.2017.11.024. Epub 2017 Dec 7.

5.

Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia.

Lafage-Pochitaloff M, Baranger L, Hunault M, Cuccuini W, Lefebvre C, Bidet A, Tigaud I, Eclache V, Delabesse E, Bilhou-Nabéra C, Terré C, Chapiro E, Gachard N, Mozziconacci MJ, Ameye G, Porter S, Grardel N, Béné MC, Chalandon Y, Graux C, Huguet F, Lhéritier V, Ifrah N, Dombret H; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL).

Blood. 2017 Oct 19;130(16):1832-1844. doi: 10.1182/blood-2017-05-783852. Epub 2017 Aug 8.

PMID:
28790105
6.

HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells.

Germini D, Tsfasman T, Klibi M, El-Amine R, Pichugin A, Iarovaia OV, Bilhou-Nabera C, Subra F, Bou Saada Y, Sukhanova A, Boutboul D, Raphaël M, Wiels J, Razin SV, Bury-Moné S, Oksenhendler E, Lipinski M, Vassetzky YS.

Leukemia. 2017 Nov;31(11):2515-2522. doi: 10.1038/leu.2017.106. Epub 2017 Mar 31.

PMID:
28360415
7.

Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia.

Hirsch P, Tang R, Abermil N, Flandrin P, Moatti H, Favale F, Suner L, Lorre F, Marzac C, Fava F, Mamez AC, Lapusan S, Isnard F, Mohty M, Legrand O, Douay L, Bilhou-Nabera C, Delhommeau F.

Haematologica. 2017 Jul;102(7):1227-1237. doi: 10.3324/haematol.2016.159681. Epub 2017 Mar 16.

8.

Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience.

Alloin AL, Leverger G, Dalle JH, Galambrun C, Bertrand Y, Baruchel A, Auvrignon A, Gandemer V, Ragu C, Loundou A, Bilhou-Nabera C, Lafage-Pochitaloff M, Dastugue N, Nelken B, Jubert C, Rialland F, Plat G, Pochon C, Vannier JP, Rohrlich PS, Kanold J, Lutz P, Sirvent A, Oudin C, Cuccuini W, Michel G.

Bone Marrow Transplant. 2017 Apr;52(4):516-521. doi: 10.1038/bmt.2016.293. Epub 2016 Dec 12.

PMID:
27941778
9.

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

Hirsch P, Zhang Y, Tang R, Joulin V, Boutroux H, Pronier E, Moatti H, Flandrin P, Marzac C, Bories D, Fava F, Mokrani H, Betems A, Lorre F, Favier R, Féger F, Mohty M, Douay L, Legrand O, Bilhou-Nabera C, Louache F, Delhommeau F.

Nat Commun. 2016 Aug 18;7:12475. doi: 10.1038/ncomms12475.

10.

Cytogenetics in the management of Philadelphia-negative myeloproliferative neoplasms: an update by the Groupe francophone de cytogénétique hématologique (GFCH).

Bilhou-Nabéra C, Bidet A, Eclache V, Lippert E, Mozziconacci MJ.

Ann Biol Clin (Paris). 2016 Oct 1;74(5):517-523. Review.

11.

Myelodysplastic syndrome with clonal cytogenetic abnormalities followed by fatal erythroid leukemia after 14 years of exposure to hydroxyurea for sickle cell anemia.

Aumont C, Driss F, Lazure T, Picard V, Creidy R, De Botton S, Saada V, Lambotte O, Bilhou-Nabera C, Tertian G, Michot JM.

Am J Hematol. 2015 Jul;90(7):E131-2. doi: 10.1002/ajh.24010. No abstract available.

12.

Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution.

Hirsch P, Labopin M, Viguié F, Perot C, Isnard F, Mamez AC, Bilhou-Nabera C, Marzac C, Delhommeau F, Lapusan S, Marie JP, Mohty M, Legrand O.

Leuk Res. 2014 Aug;38(8):907-12. doi: 10.1016/j.leukres.2014.05.021. Epub 2014 Jun 4.

PMID:
24957411
13.

Differences in transcription patterns between induced pluripotent stem cells produced from the same germ layer are erased upon differentiation.

Pirozhkova I, Barat A, Dmitriev P, Kim E, Robert T, Guégan J, Bilhou-Nabera C, Busato F, Tost J, Carnac G, Laoudj-Chenivesse D, Lipinski M, Vassetzky Y.

PLoS One. 2013;8(1):e53033. doi: 10.1371/journal.pone.0053033. Epub 2013 Jan 9.

14.

Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome.

Mahlaoui N, Pellier I, Mignot C, Jais JP, Bilhou-Nabéra C, Moshous D, Neven B, Picard C, de Saint-Basile G, Cavazzana-Calvo M, Blanche S, Fischer A.

Blood. 2013 Feb 28;121(9):1510-6. doi: 10.1182/blood-2012-08-448118. Epub 2012 Dec 20.

PMID:
23264593
15.

Thrombopoietin-increased DNA-PK-dependent DNA repair limits hematopoietic stem and progenitor cell mutagenesis in response to DNA damage.

de Laval B, Pawlikowska P, Petit-Cocault L, Bilhou-Nabera C, Aubin-Houzelstein G, Souyri M, Pouzoulet F, Gaudry M, Porteu F.

Cell Stem Cell. 2013 Jan 3;12(1):37-48. doi: 10.1016/j.stem.2012.10.012. Epub 2012 Dec 13.

16.

Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.

Nguyen-Khac F, Lambert J, Chapiro E, Grelier A, Mould S, Barin C, Daudignon A, Gachard N, Struski S, Henry C, Penther D, Mossafa H, Andrieux J, Eclache V, Bilhou-Nabera C, Luquet I, Terre C, Baranger L, Mugneret F, Chiesa J, Mozziconacci MJ, Callet-Bauchu E, Veronese L, Blons H, Owen R, Lejeune J, Chevret S, Merle-Beral H, Leblondon V; Groupe Français d'Etude de la Leucémie Lymphoïde Chronique et Maladie de Waldenström (GFCLL/MW); Groupe Ouest-Est d’étude des Leucémie Aiguës et Autres Maladies du Sang (GOELAMS); Groupe d’Etude des Lymphomes de l’Adulte (GELA).

Haematologica. 2013 Apr;98(4):649-54. doi: 10.3324/haematol.2012.070458. Epub 2012 Oct 12.

17.

Clinical profile and genetic basis of Wiskott-Aldrich syndrome at Chandigarh, North India.

Suri D, Singh S, Rawat A, Gupta A, Kamae C, Honma K, Nakagawa N, Imai K, Nonoyama S, Oshima K, Mitsuiki N, Ohara O, Bilhou-Nabera C, Proust A, Ahluwalia J, Dogra S, Saikia B, Minz RW, Sehgal S.

Asian Pac J Allergy Immunol. 2012 Mar;30(1):71-8.

18.

Diagnosis of Burkitt lymphoma using an algorithmic approach--applicable in both resource-poor and resource-rich countries.

Naresh KN, Ibrahim HA, Lazzi S, Rince P, Onorati M, Ambrosio MR, Bilhou-Nabera C, Amen F, Reid A, Mawanda M, Calbi V, Ogwang M, Rogena E, Byakika B, Sayed S, Moshi E, Mwakigonja A, Raphael M, Magrath I, Leoncini L.

Br J Haematol. 2011 Sep;154(6):770-6. doi: 10.1111/j.1365-2141.2011.08771.x. Epub 2011 Jul 1.

PMID:
21718280
19.

The c.273+11dup genetic change in the WAS gene is a functionally neutral polymorphism.

Jeanson-Leh L, Charrier S, Proust A, Bilhou-Nabéra C, Favier R, Deswarte C, Bordigoni P, Galy A, Delaunay J.

Eur J Haematol. 2011 Oct;87(4):366-71. doi: 10.1111/j.1600-0609.2011.01674.x. Epub 2011 Aug 11.

PMID:
21711396
20.

FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis.

Desterke C, Bilhou-Nabéra C, Guerton B, Martinaud C, Tonetti C, Clay D, Guglielmelli P, Vannucchi A, Bordessoule D, Hasselbalch H, Dupriez B, Benzoubir N, Bourgeade MF, Pierre-Louis O, Lazar V, Vainchenker W, Bennaceur-Griscelli A, Gisslinger H, Giraudier S, Le Bousse-Kerdilès MC; French Intergroup of Myeloproliferative Disorders,; French INSERM; European EUMNET Networks on Myelofibrosis.

Cancer Res. 2011 Apr 15;71(8):2901-15. doi: 10.1158/0008-5472.CAN-10-1731. Epub 2011 Apr 12. Erratum in: Cancer Res. 2011 Jun 1;71(11):4049-50.

21.

Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations.

Nguyen-Khac F, Lesty C, Eclache V, Couronné L, Kosmider O, Andrieux J, Collonge-Rame MA, Penther D, Lafage M, Bilhou-Nabera C, Chapiro E, Mozziconacci MJ, Mugneret F, Gachard N, Nadal N, Lippert E, Struski S, Dastugue N, Cabrol C, Bernard OA; Groupe Francophone de Cytogénétique Hématologique.

Genes Chromosomes Cancer. 2010 Oct;49(10):919-27. doi: 10.1002/gcc.20802.

PMID:
20629097
22.

[Elderly patients with myelodysplastic syndrome with del 5q receiving lenalidomide: two case reports with poor prognosis].

Reibel F, Debord C, Bouhadiba S, Chaïbi P, Bilhou-Nabera C, Le Garff M, Gouin-Thibault I, Siguret V.

Ann Biol Clin (Paris). 2010 Mar-Apr;68(2):248-53. doi: 10.1684/abc.2010.0426. French.

23.

Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia.

Put N, Meeus P, Chatelain B, Rack K, Boeckx N, Nollet F, Graux C, Van Den Neste E, Janssens A, Madoe V, Van Hoof A, Bilhou-Nabera C, Wlodarska I, Vandenberghe P, Michaux L.

Leukemia. 2009 Jun;23(6):1201-4. doi: 10.1038/leu.2009.44. Epub 2009 Mar 19. No abstract available.

PMID:
19295547
24.

Multifocal deficits due to leukemic meningoradiculitis in chronic lymphocytic leukemia.

Denier C, Tertian G, Ribrag V, Lozeron P, Bilhou-Nabera C, Lazure T, Abbed K, Lacroix C, Adams D.

J Neurol Sci. 2009 Feb 15;277(1-2):130-2. doi: 10.1016/j.jns.2008.11.003. Epub 2008 Dec 19.

PMID:
19100998
25.

New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11).

El Andaloussi A, Bilhou-Nabera C.

J Biomed Biotechnol. 2007;2007(7):92385. doi: 10.1155/2007/92385.

26.

Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancy.

Capovilla M, Cayuela JM, Bilhou-Nabera C, Gardin C, Letestu R, Baran-Marzak F, Fenaux P, Martin A.

Eur J Haematol. 2008 Jan;80(1):81-6. Epub 2007 Nov 19.

PMID:
18028420
27.

Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH).

Luquet I, Laï JL, Barin C, Baranger L, Bilhou-Nabera C, Lippert E, Gervais C, Talmant P, Cornillet-Lefebvre P, Perot C, Nadal N, Mozziconacci MJ, Lafage-Pochitaloff M, Eclache V, Mugneret F, Lefebvre C, Herens C, Speleman F, Poirel H, Tigaud I, Cabrol C, Rousselot P, Daliphard S, Imbert M, Garand R, Geneviève F, Berger R, Terre C; Francophone de Cytogenetique Hematologique.

Leukemia. 2008 Jan;22(1):132-7. Epub 2007 Oct 11.

PMID:
17928884
28.

Expression of HMGA2 in PB leukocytes and purified CD34+ cells from controls and patients with Myelofibrosis and myeloid metaplasia.

Andrieux J, Bilhou-Nabera C, Lippert E, Le Bousse-Kerdiles MC, Dupriez B, Grardel N, Pierre-Louis O, Desterke C, Praloran V, Laï JL, Demory JL.

Leuk Lymphoma. 2006 Sep;47(9):1956-9. No abstract available.

PMID:
17065012
29.

Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience.

Picard C, Hayette S, Bilhou-Nabera C, Cayuela JM, Delabesse E, Frenoy N, Preudhomme C, Dupont M, Bastard C, Bories D, Vaerman JL, Davi F, Dastugue N, Raynaud S, Lafage M, Deschaseaux F, Fest T, Gaub MP, Lhéritier V, Thomas X, Charrin C, Boucheix C, Dombret H, Macintyre E, Fière D, Gabert J.

Leukemia. 2006 Dec;20(12):2178-81. Epub 2006 Oct 12. No abstract available.

PMID:
17039237
30.

Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study.

Delannoy A, Delabesse E, Lhéritier V, Castaigne S, Rigal-Huguet F, Raffoux E, Garban F, Legrand O, Bologna S, Dubruille V, Turlure P, Reman O, Delain M, Isnard F, Coso D, Raby P, Buzyn A, Caillères S, Darre S, Fohrer C, Sonet A, Bilhou-Nabera C, Béné MC, Dombret H, Berthaud P, Thomas X.

Leukemia. 2006 Sep;20(9):1526-32. Epub 2006 Jul 13.

PMID:
16838024
31.

NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique.

Romana SP, Radford-Weiss I, Ben Abdelali R, Schluth C, Petit A, Dastugue N, Talmant P, Bilhou-Nabera C, Mugneret F, Lafage-Pochitaloff M, Mozziconacci MJ, Andrieu J, Lai JL, Terre C, Rack K, Cornillet-Lefebvre P, Luquet I, Nadal N, Nguyen-Khac F, Perot C, Van den Akker J, Fert-Ferrer S, Cabrol C, Charrin C, Tigaud I, Poirel H, Vekemans M, Bernard OA, Berger R; Groupe Francophone de Cytogénétique Hématologique.

Leukemia. 2006 Apr;20(4):696-706.

PMID:
16467868
32.

Cryptic 6p21.3 duplications and triplication involving HMGA1 partially masked by add 6p in four cases of myelodysplasia.

Andrieux J, Geffroy S, Bilhou-Nabera C, Dupriez B, Demory JL, Bauters F, Laï JL, Dastugue N.

Cancer Genet Cytogenet. 2006 Jan 1;164(1):84-7.

PMID:
16364769
33.

CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients.

La Starza R, Aventin A, Crescenzi B, Gorello P, Specchia G, Cuneo A, Angioni A, Bilhou-Nabera C, Boqué C, Foà R, Uyttebroeck A, Talmant P, Cimino G, Martelli MF, Marynen P, Mecucci C, Hagemeijer A.

Leukemia. 2005 Sep;19(9):1696-9. No abstract available.

PMID:
15990865
34.

A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL).

Charrin C, Thomas X, Ffrench M, Le QH, Andrieux J, Mozziconacci MJ, Laï JL, Bilhou-Nabera C, Michaux L, Bernheim A, Bastard C, Mossafa H, Perot C, Maarek O, Boucheix C, Lheritier V, Delannoy A, Fière D, Dastugue N.

Blood. 2004 Oct 15;104(8):2444-51. Epub 2004 Mar 23.

PMID:
15039281
35.

t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).

Berger R, Dastugue N, Busson M, Van Den Akker J, Pérot C, Ballerini P, Hagemeijer A, Michaux L, Charrin C, Pages MP, Mugneret F, Andrieux J, Talmant P, Hélias C, Mauvieux L, Lafage-Pochitaloff M, Mozziconacci MJ, Cornillet-Lefebvre P, Radford I, Asnafi V, Bilhou-Nabera C, Nguyen Khac F, Léonard C, Speleman F, Poppe B, Bastard C, Taviaux S, Quilichini B, Herens C, Grégoire MJ, Cavé H, Bernard OA; Groupe Français de Cytogénétique Hématologique (GFCH).

Leukemia. 2003 Sep;17(9):1851-7.

PMID:
12970786
36.

Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?

Bilhou-Nabéra C, Brigaudeau C, Clay D, Andrieux J, Lai JL, Brouty-Boyé D, Vignon C, Gharbi MJ, Le Bousse-Kerdilès MC, Praloran V; French INSERM Network o Myeloid Metaplasia with Myelofibrosis.

Blood. 2003 Aug 15;102(4):1551-2. No abstract available.

PMID:
12900353
37.

Derivative (7)t(7;8)(q34;q21). a new additional cytogenetic abnormality in acute promyelocytic leukemia.

Vial JP, Mahon FX, Pigneux A, Notz A, Lacombe F, Reiffers J, Bilhou-Nabera C.

Cancer Genet Cytogenet. 2003 Jan 1;140(1):78-81.

PMID:
12550765
38.

Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia.

Martini A, La Starza R, Janssen H, Bilhou-Nabera C, Corveleyn A, Somers R, Aventin A, Foà R, Hagemeijer A, Mecucci C, Marynen P.

Cancer Res. 2002 Oct 1;62(19):5408-12.

39.

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.

Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X, Delannoy A, Buzyn A, Bilhou-Nabera C, Cayuela JM, Fenaux P, Bourhis JH, Fegueux N, Charrin C, Boucheix C, Lhéritier V, Espérou H, MacIntyre E, Vernant JP, Fière D; Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group).

Blood. 2002 Oct 1;100(7):2357-66.

PMID:
12239143
40.

Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH).

Dastugue N, Lafage-Pochitaloff M, Pagès MP, Radford I, Bastard C, Talmant P, Mozziconacci MJ, Léonard C, Bilhou-Nabéra C, Cabrol C, Capodano AM, Cornillet-Lefebvre P, Lessard M, Mugneret F, Pérot C, Taviaux S, Fenneteaux O, Duchayne E, Berger R; Groupe Français d'Hematologie Cellulaire.

Blood. 2002 Jul 15;100(2):618-26.

PMID:
12091356
41.

Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission.

Delannoy A, Cazin B, Thomas X, Bouabdallah R, Boiron JM, Huguet F, Straetmans N, Zérazhi H, Vernant JP, Dombret H, Bilhou-Nabera C, Charrin C, Boucheix C, Sebban C, Lhéritier V, Fière D; LALA Group, France and Belgium.

Leuk Lymphoma. 2002 Jan;43(1):75-81.

PMID:
11908739
42.

Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa.

Mahon FX, Delbrel X, Cony-Makhoul P, Fabères C, Boiron JM, Barthe C, Bilhou-Nabéra C, Pigneux A, Marit G, Reiffers J.

J Clin Oncol. 2002 Jan 1;20(1):214-20.

PMID:
11773172
43.

Expression of interferon-alpha (IFN-alpha) receptor 2c at diagnosis is associated with cytogenetic response in IFN-alpha-treated chronic myeloid leukemia.

Barthe C, Mahon FX, Gharbi MJ, Fabères C, Bilhou-Nabéra C, Hochhaus A, Reiffers J, Marit G.

Blood. 2001 Jun 1;97(11):3568-73.

PMID:
11369652
44.

The value of interphase fluorescence in situ hybridization for the detection of translocation t(12;21) in childhood acute lymphoblastic leukemia.

Ameye G, Jacquy C, Zenebergh A, Stul M, Vaerman JL, Bilhou-Nabera C, Libouton JM, Deneys V, Martiat P, Hagemeijer A, Cornu G, Verellen-Dumoulin C, Michaux L.

Ann Hematol. 2000 May;79(5):259-68.

PMID:
10870481
45.

Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13).

Cools J, Bilhou-Nabera C, Wlodarska I, Cabrol C, Talmant P, Bernard P, Hagemeijer A, Marynen P.

Blood. 1999 Sep 1;94(5):1820-4.

PMID:
10477709
46.

Autologous stem cell transplantation in chronic myeloid leukemia: a single center experience.

Pigneux A, Faberes C, Boiron JM, Mahon FX, Cony-Makhoul P, Agape P, Lounici A, Bernard P, Bilhou-Nabera C, Bouzgarrou R, Marit G, Reiffers J.

Bone Marrow Transplant. 1999 Aug;24(3):265-70.

47.

Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered.

van der Reijden BA, Dauwerse HG, Giles RH, Jagmohan-Changur S, Wijmenga C, Liu PP, Smit B, Wessels HW, Beverstock GC, Jotterand-Bellomo M, Martinet D, Mühlematter D, Lafage-Pochitaloff M, Gabert J, Reiffers J, Bilhou-Nabera C, van Ommen GJ, Hagemeijer A, Breuning MH.

Oncogene. 1999 Jan 14;18(2):543-50.

48.

[Nuclear transcription factor kappa B (NF-kappa B)].

Mercié P, Seigneur M, Bilhou-Nabera C, Boisseau MR, Bernard P.

Rev Med Interne. 1998 Dec;19(12):945-7. Review. French.

PMID:
9887469
49.

Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha.

Mahon FX, Fabères C, Pueyo S, Cony-Makhoul P, Salmi R, Boiron JM, Marit G, Bilhou-Nabera C, Carrère A, Montastruc M, Pigneux A, Bernard P, Reiffers J.

Blood. 1998 Dec 1;92(11):4059-65.

PMID:
9834210
50.

Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.

Cotteret S, Belloc F, Boiron JM, Bilhou-Nabera C, Dumain P, Boyer C, Lacombe F, Reiffers J, Bernard P.

Cytometry. 1998 Oct 15;34(5):216-22.

PMID:
9822307

Supplemental Content

Loading ...
Support Center